{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:45:03Z","timestamp":1794883503521,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bioorg.2019.02.009","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T11:44:59Z","timestamp":1549280699000},"page":"305-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, \u03b1-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2)"],"prefix":"10.1016","volume":"86","author":[{"given":"Ghulam","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al Harrasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidayat","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hamaed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.02.009_b0005","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bioorg.2019.02.009_b0010","first-page":"195","article-title":"Drug therapy for the cardiac complications of diabetes","volume":"1","author":"Connelly","year":"2004","journal-title":"Drug Discovery Today: Therapeutic Strategies"},{"issue":"5","key":"10.1016\/j.bioorg.2019.02.009_b0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1021\/acsmedchemlett.6b00027","article-title":"Discovery of novel tricyclic heterocycles as potent and selective DPP-4 inhibitors for the treatment of type 2 diabetes","volume":"7","author":"Wu","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2019.02.009_b0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.phymed.2012.09.009","article-title":"Antihyperglycemic activity with DPP-IV inhibition of alkaloids from seed extract of Castanospermum australe: Investigation by experimental validation and molecular docking","volume":"20","author":"Bharti","year":"2012","journal-title":"Phytomedicine"},{"issue":"12","key":"10.1016\/j.bioorg.2019.02.009_b0025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1542\/pir.29.12.431","article-title":"Management of diabetic ketoacidosis in children and adolescents","volume":"29","author":"Cooke","year":"2008","journal-title":"Pediatr Rev."},{"issue":"14","key":"10.1016\/j.bioorg.2019.02.009_b0030","doi-asserted-by":"crossref","first-page":"6772","DOI":"10.1021\/acs.jmedchem.6b00505","article-title":"Discovery and rational design of natural-product-derived 2-phenyl-3, 4-dihydro-2 H-benzo [f] chromen-3-amine analogs as novel and potent dipeptidyl peptidase 4 (DPP-4) inhibitors for the treatment of type 2 diabetes","volume":"59","author":"Li","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.02.009_b0035","first-page":"8","article-title":"Rapid screening for \u03b1-glucosidase inhibitors from Gymnema sylvestre by affinity ultrafiltration\u2013HPLC-MS","author":"Chen","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.bioorg.2019.02.009_b0040","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1021\/jm070104l","article-title":"Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV","volume":"50","author":"Feng","year":"2007","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2019.02.009_b0045","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/14756360802610761","article-title":"Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine","volume":"24","author":"Al-Masri","year":"2009","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.02.009_b0050","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/479505","article-title":"Berry and citrus phenolic compounds inhibit dipeptidyl peptidase IV: Implications in diabetes management","author":"Fan","year":"2013","journal-title":"Evidence-Based Complementary Alternative Medicine"},{"issue":"6","key":"10.1016\/j.bioorg.2019.02.009_b0055","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1021\/jm400658e","article-title":"Dipeptidyl peptidase IV and its inhibitors: Therapeutics for type 2 diabetes and what else?","volume":"57","author":"Juillerat-Jeanneret","year":"2013","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2019.02.009_b0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0031-9422(02)00104-8","article-title":"ul Hussan SS, Choudhary MI. inhibition of \u03b1-glucosidase by oleanolic acid and its synthetic derivatives","volume":"60","author":"Ali","year":"2002","journal-title":"Phytochemistry"},{"issue":"2","key":"10.1016\/j.bioorg.2019.02.009_b0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3177\/jnsv.52.149","article-title":"Inhibition of \u03b1-glucosidase and \u03b1-amylase by flavonoids","volume":"52","author":"Tadera","year":"2006","journal-title":"J. Nutr. Sci. Vitaminol."},{"issue":"2","key":"10.1016\/j.bioorg.2019.02.009_b0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1078\/0944-7113-00065","article-title":"Alpha-glucosidase inhibition from a Chinese medical herb (Ramulus mori) in normal and diabetic rats and mice","volume":"9","author":"Ye","year":"2002","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.bioorg.2019.02.009_b0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1479164112441524","article-title":"Alpha-glucosidase inhibitors 2012\u2013cardiovascular considerations and trial evaluation","volume":"9","author":"Standl","year":"2012","journal-title":"Diabetes Vascular Disease Res"},{"issue":"6","key":"10.1016\/j.bioorg.2019.02.009_b0080","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2147\/VHRM.S3119","article-title":"Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes","volume":"4","author":"van de Laar","year":"2008","journal-title":"Vascular Health Risk Manage."},{"issue":"2","key":"10.1016\/j.bioorg.2019.02.009_b0085","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.lwt.2013.04.002","article-title":"Evaluation of \u03b1-glucosidase inhibition potential of some flavonoids from Epimedium brevicornum","volume":"53","author":"Phan","year":"2013","journal-title":"LWT-Food Sci. Technol."},{"key":"10.1016\/j.bioorg.2019.02.009_b0090","series-title":"Screening of \u03b1 -Glucosidase Inhibitory Activity from Some Plants of Apocynaceae","author":"Elya","year":"2012"},{"issue":"8","key":"10.1016\/j.bioorg.2019.02.009_b0095","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrendo.2011.243","article-title":"SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects","volume":"8","author":"Ferrannini","year":"2012","journal-title":"Nature Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.bioorg.2019.02.009_b0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40265-014-0337-y","article-title":"Pharmacodynamics, efficacy and safety of sodium\u2013glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus","volume":"75","author":"Scheen","year":"2015","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.bioorg.2019.02.009_b0105","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1039\/C4NP00064A","article-title":"Natural product and natural product derived drugs in clinical trials","volume":"31","author":"Butler","year":"2014","journal-title":"Nat. Prod. Rep."},{"issue":"3","key":"10.1016\/j.bioorg.2019.02.009_b0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1590\/S0100-40422002000300016","article-title":"Medicinal plants: the need for multidisciplinary scientific studies","volume":"25","author":"Maciel","year":"2002","journal-title":"Qu\u00edmica Nova."},{"issue":"17","key":"10.1016\/j.bioorg.2019.02.009_b0115","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.9734\/BJPR\/2014\/8382","article-title":"Natural products as potential sources of antidiabetic drugs","volume":"4","author":"Osadebe","year":"2014","journal-title":"British J. Pharmaceut. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2019.02.009_b0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J Nat Prod."},{"issue":"2","key":"10.1016\/j.bioorg.2019.02.009_b0125","first-page":"113","article-title":"Antidiabetic potential of medicinal plants","volume":"67","author":"Neelesh","year":"2010","journal-title":"Acta Poloniae Pharmaceutica -Drug Res"},{"key":"10.1016\/j.bioorg.2019.02.009_b0130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1055\/s-2002-32894","article-title":"Recommended testing in diabetes research","volume":"68","author":"Verspohl","year":"2002","journal-title":"Planta Med."},{"issue":"1","key":"10.1016\/j.bioorg.2019.02.009_b0135","first-page":"7","article-title":"Ethnophytotherapical approaches for the treatment of diabetes by the local inhabitants of district Attock (Pakistan)","volume":"2004","author":"Ahmad","year":"2006","journal-title":"Ethnobotanical leaflets"},{"issue":"1","key":"10.1016\/j.bioorg.2019.02.009_b0140","first-page":"32","article-title":"Indigenous uses of some important ethnomedicinal herbs of Ayubia National Park, Abbottabad, Pakistan","volume":"2006","author":"Gilani","year":"2006","journal-title":"Ethnobotanical Leaflets"},{"issue":"16","key":"10.1016\/j.bioorg.2019.02.009_b0145","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1021\/jm200383j","article-title":"Structure-Activity Relationship Studies on Isoindoline Inhibitors of Dipeptidyl Peptidases 8 and 9 (DPP8, DPP9): Is DPP8-Selectivity an Attainable Goal?","volume":"54","author":"Van Goethem","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.02.009_b0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jep.2014.08.017","article-title":"Plants Fagonia cretica L. and Hedera nepalensis K. Koch contain natural compounds with potent dipeptidyl peptidase-4 (DPP-4) inhibitory activity","volume":"156","author":"Saleem","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.bioorg.2019.02.009_b0155","first-page":"471","article-title":"Fast and effective identification of the bioactive compounds and their targets from medicinal plants via computational chemical biology approach","volume":"2","author":"Zhang","year":"2011","journal-title":"Med ChemComm."},{"issue":"26","key":"10.1016\/j.bioorg.2019.02.009_b0160","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1021\/jf500639f","article-title":"Bioactive compounds from culinary herbs inhibit a molecular target for type 2 diabetes management, dipeptidyl peptidase IV","volume":"62","author":"Bower","year":"2014","journal-title":"J. Agric. Food. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2019.02.009_b0165","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1039\/C7FO00220C","article-title":"Differential \u03b1-amylase\/\u03b1-glucosidase inhibitory activities of plant-derived phenolic compounds: a virtual screening perspective for the treatment of obesity and diabetes","volume":"8","author":"Rasouli","year":"2017","journal-title":"Food Funct."},{"issue":"3","key":"10.1016\/j.bioorg.2019.02.009_b0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.lfs.2012.11.022","article-title":"Studies on \u03b1-glucosidase inhibition and anti-glycation potential of Iris loczyi and Iris unguicularis","volume":"92","author":"Mosihuzzman","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2019.02.009_b0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.foodchem.2016.03.079","article-title":"Antioxidants and \u03b1-glucosidase inhibitors from Ipomoea batatas leaves identified by bioassay-guided approach and structure-activity relationships","volume":"208","author":"Zhang","year":"2016","journal-title":"Food Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2019.02.009_b0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1749-8546-8-19","article-title":"Flavonoids with \u03b1-glucosidase inhibitory activities and their contents in the leaves of Morus atropurpurea","volume":"8","author":"Hong","year":"2013","journal-title":"Chinese Medicine"},{"key":"10.1016\/j.bioorg.2019.02.009_b0185","first-page":"3","article-title":"Antidiabetic activity of Terminalia sericea Burch. Ex DC constituents","volume":"36","author":"Nkobole","year":"2011","journal-title":"Nat. Prod. Commun."},{"issue":"2","key":"10.1016\/j.bioorg.2019.02.009_b0190","doi-asserted-by":"crossref","first-page":"e0116922","DOI":"10.1371\/journal.pone.0116922","article-title":"Rapid identification of \u03b1-glucosidase inhibitors from Phlomis tuberosa by sepbox chromatography and thin-layer chromatography bioautography","volume":"10","author":"Yang","year":"2015","journal-title":"PloS one"},{"issue":"5","key":"10.1016\/j.bioorg.2019.02.009_b0195","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/ptr.2661","article-title":"Triterpene acids isolated from Lagerstroemia speciosa leaves as \u03b1-glucosidase inhibitors","volume":"23","author":"Hou","year":"2009","journal-title":"Phytotherapy Res"},{"issue":"9","key":"10.1016\/j.bioorg.2019.02.009_b0200","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3390\/molecules21091136","article-title":"Sodium-glucose cotransporter 2 (SGLT2) inhibitors from natural products: discovery of next-generation antihyperglycemic agents","volume":"21","author":"Choi","year":"2016","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.bioorg.2019.02.009_b0205","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2337\/diabetes.48.9.1794","article-title":"T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes","volume":"48","author":"Oku","year":"1999","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.bioorg.2019.02.009_b0210","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/jm701272q","article-title":"Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes","volume":"51","author":"Meng","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.02.009_b0215","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.bmc.2007.03.011","article-title":"Na +-glucose cotransporter (SGLT) inhibitory flavonoids from the roots of Sophora flavescens","volume":"15","author":"Sato","year":"2007","journal-title":"Bioorg. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818310411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818310411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:28:51Z","timestamp":1794504531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818310411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":43,"alternative-id":["S0045206818310411"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.02.009","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, \u03b1-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}